Clustering data with hclust algorithm for (Study ST002498)

Reversed phase POSITIVE ION MODE (Analysis AN004655)
MetaboliteStructureF1F2
1-(1-enyl-stearoyl)-2-oleoyl-GPE (P-18:0/18:1)ME7404190.971.04
1-arachidonoyl-GPE (20:4n6)*ME7403610.971.04
1-(1-enyl-palmitoyl)-2-linoleoyl-GPC (P-16:0/18:2)*ME7404431.001.00
1,2-dilinoleoyl-GPC (18:2/18:2)ME7404141.020.98
1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (P-18:0/20:4)*ME7404390.971.03
1-arachidonoyl-GPC (20:4n6)*ME7403570.981.03
1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2)*ME7404520.991.02
1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0)*ME7404580.991.01
1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1)*ME7404420.991.01
1-(1-enyl-palmitoyl)-2-oleoyl-GPE (P-16:0/18:1)*ME7404410.971.03
1-(1-enyl-oleoyl)-GPE (P-18:1)*ME7403980.991.01
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)*ME7404400.981.02
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4)*ME7404440.991.01
10-hydroxywarfarinME7405281.120.95
1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1)*ME7404571.010.98
1-lignoceroyl-GPC (24:0)ME7403821.010.99
1-(1-enyl-palmitoyl)-GPC (P-16:0)*ME7403830.991.02
1-(1-enyl-stearoyl)-2-linoleoyl-GPE (P-18:0/18:2)*ME7404610.971.03
1-(1-enyl-stearoyl)-GPE (P-18:0)*ME7403860.981.03
1-(1-enyl-palmitoyl)-GPE (P-16:0)*ME7403850.981.02
1,2-dilinoleoyl-GPE (18:2/18:2)*ME7404591.010.99
1,2-dipalmitoyl-GPC (16:0/16:0)ME7403421.001.00

Factors:

F1Diagnosis:0
F2Diagnosis:1
Data matrix
  logo